3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Thoracic
1
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Colorectal Neoplasms
16
Stomach Neoplasms
7
Melanoma
7
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Hepatocellular
6
Neoplasms
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Colonic Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Renal Cell
3
Carcinoma, Merkel Cell
3
Anus Neoplasms
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Interventions
Bevacizumab
6
Nivolumab
5
pembrolizumab
4
Gemcitabine
4
Cisplatin
3
regorafenib
2
fludarabine
2
Sorafenib
2
Paclitaxel
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Drug Therapy
2
Cyclophosphamide
2
Azacitidine
2
vocimagene amiretrorepvec
1
ulixertinib
1
temsirolimus
1
spartalizumab
1
sonidegib
1
selinexor
1
sargramostim
1
sacituzumab govitecan
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olutasidenib
1
olaparib
1
motexafin gadolinium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Interleukin-2
×
Gastrointestinal
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled